The U.S. Food and Drug Administration (FDA) has backed European plans to use whole genome sequencing (WGS) to help solve outbreaks.
The European Commission recently asked for comments on potential legislation requiring EU countries to do WGS during foodborne outbreaks.
The FDA said the proposed regulation would “significantly improve food
Continue Reading FDA supports EU’s WGS outbreak plan; food industry groups voice concerns
The U.S. Food and Drug Administration and the Federal Trade Commission have issued warning letters to five companies for illegally selling copycat products containing delta-8 THC, which mimic popular national brands, violating the Federal Food, Drug, and Cosmetic Act.
The companies — Hippy Mood, Earthly Hemps, Shamrockshrooms.com, Mary Janes Bakery
Continue Reading FDA and FTC warn companies about illegal delta-8 THC copycat snacks
China’s concerns about a U.S. Food and Drug Administration (FDA) import alert was one of six new issues discussed at a recent World Trade Organization (WTO) meeting.
Delegates at the June meeting of the WTO Committee on Sanitary and Phytosanitary (SPS) Measures addressed trade concerns related to food safety and
Continue Reading U.S. import alert among topics at WTO meeting
Most technical aspects related to sequencing have been solved but data sharing and trust remain key issues, according to experts in Europe.
The European Food Safety Authority (EFSA) and EU Commission’s Inter-European Union Reference Laboratories (EURL) Working Group on Next Genome Sequencing (NGS) organized the second Science Meets Policy conference
Continue Reading Data sharing and trust highlighted at EFSA WGS event
The U.S. Food and Drug Administration (FDA) has issued a cautionary advisory to consumers, urging them not to feed their pets specific lots of raw cat food and dog food produced by Arrow Reliance Inc.’s brand, Darwin’s Natural Pet Products. The agency’s move comes after samples from the affected lots
Continue Reading FDA issues advisory over Darwin’s Natural Pet Products over Salmonella concerns